Insider Transactions in Q2 2021 at Nabriva Therapeutics PLC (NBRV)
Insider Transaction List (Q2 2021)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Jun 30
2021
|
Robert Crotty Gen Counsel & Corp Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
37
-0.09%
|
$37
$1.35 P/Share
|
Jun 30
2021
|
Steven P. Gelone Director |
SELL
Payment of exercise price or tax liability
|
Direct |
63
-0.02%
|
$63
$1.35 P/Share
|
Jun 30
2021
|
Theodore R Schroeder Director |
SELL
Payment of exercise price or tax liability
|
Direct |
107
-0.06%
|
$107
$1.35 P/Share
|
Jun 06
2021
|
Robert Crotty Gen Counsel & Corp Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
73
-0.18%
|
$73
$1.34 P/Share
|
Jun 06
2021
|
Steven P. Gelone Director |
SELL
Payment of exercise price or tax liability
|
Direct |
92
-0.03%
|
$92
$1.34 P/Share
|
Jun 06
2021
|
Theodore R Schroeder Director |
SELL
Payment of exercise price or tax liability
|
Direct |
225
-0.13%
|
$225
$1.34 P/Share
|
May 31
2021
|
Steven P. Gelone Director |
SELL
Payment of exercise price or tax liability
|
Direct |
63
-0.02%
|
$63
$1.38 P/Share
|
May 31
2021
|
Robert Crotty Gen Counsel & Corp Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
37
-0.09%
|
$37
$1.38 P/Share
|
May 31
2021
|
Theodore R Schroeder Director |
SELL
Payment of exercise price or tax liability
|
Direct |
107
-0.06%
|
$107
$1.38 P/Share
|
May 06
2021
|
Robert Crotty Gen Counsel & Corp Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
74
-0.18%
|
$74
$1.49 P/Share
|
May 06
2021
|
Steven P. Gelone Director |
SELL
Payment of exercise price or tax liability
|
Direct |
92
-0.03%
|
$92
$1.49 P/Share
|
May 06
2021
|
Theodore R Schroeder Director |
SELL
Payment of exercise price or tax liability
|
Direct |
225
-0.13%
|
$225
$1.49 P/Share
|
Apr 30
2021
|
Theodore R Schroeder Director |
SELL
Payment of exercise price or tax liability
|
Direct |
107
-0.06%
|
$107
$1.78 P/Share
|
Apr 30
2021
|
Steven P. Gelone Director |
SELL
Payment of exercise price or tax liability
|
Direct |
63
-0.02%
|
$63
$1.78 P/Share
|
Apr 30
2021
|
Robert Crotty Gen Counsel & Corp Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
37
-0.09%
|
$37
$1.78 P/Share
|
Apr 28
2021
|
Steven P. Gelone Director |
BUY
Grant, award, or other acquisition
|
Direct |
290,697
+44.17%
|
-
|
Apr 06
2021
|
Robert Crotty Gen Counsel & Corp Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
74
-0.18%
|
$74
$1.73 P/Share
|
Apr 06
2021
|
Steven P. Gelone Director |
SELL
Payment of exercise price or tax liability
|
Direct |
92
-0.12%
|
$92
$1.73 P/Share
|
Apr 06
2021
|
Theodore R Schroeder Director |
SELL
Payment of exercise price or tax liability
|
Direct |
225
-0.13%
|
$225
$1.73 P/Share
|